KR20070012644A - 약학 화합물의 결정체 형태 - Google Patents

약학 화합물의 결정체 형태 Download PDF

Info

Publication number
KR20070012644A
KR20070012644A KR1020067017263A KR20067017263A KR20070012644A KR 20070012644 A KR20070012644 A KR 20070012644A KR 1020067017263 A KR1020067017263 A KR 1020067017263A KR 20067017263 A KR20067017263 A KR 20067017263A KR 20070012644 A KR20070012644 A KR 20070012644A
Authority
KR
South Korea
Prior art keywords
compound
crystalline
solid
measured
diffraction pattern
Prior art date
Application number
KR1020067017263A
Other languages
English (en)
Korean (ko)
Inventor
마이클 해롤드 락
데 디고 헤이디 로페
킴 라세 크리스텐센
올레 닐센
안데르스 부르
마크 호웰스
Original Assignee
하. 룬트벡 아크티에 셀스카브
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하. 룬트벡 아크티에 셀스카브 filed Critical 하. 룬트벡 아크티에 셀스카브
Publication of KR20070012644A publication Critical patent/KR20070012644A/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1020067017263A 2004-02-27 2005-02-24 약학 화합물의 결정체 형태 KR20070012644A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200400326 2004-02-27
DKPA200400326 2004-02-27

Publications (1)

Publication Number Publication Date
KR20070012644A true KR20070012644A (ko) 2007-01-26

Family

ID=36607170

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067017263A KR20070012644A (ko) 2004-02-27 2005-02-24 약학 화합물의 결정체 형태

Country Status (10)

Country Link
KR (1) KR20070012644A (es)
CN (1) CN100591685C (es)
AR (1) AR047821A1 (es)
CA (1) CA2762878C (es)
EA (1) EA200601566A1 (es)
ES (1) ES2397342T3 (es)
HK (1) HK1102087A1 (es)
TW (1) TW200530254A (es)
UA (1) UA90259C2 (es)
ZA (1) ZA200606556B (es)

Also Published As

Publication number Publication date
AR047821A1 (es) 2006-02-22
TW200530254A (en) 2005-09-16
EA200601566A1 (ru) 2006-12-29
CA2762878A1 (en) 2005-09-09
UA90259C2 (en) 2010-04-26
CN100591685C (zh) 2010-02-24
ES2397342T3 (es) 2013-03-06
ZA200606556B (en) 2008-02-27
HK1102087A1 (en) 2007-11-02
CA2762878C (en) 2014-08-19
CN1922196A (zh) 2007-02-28

Similar Documents

Publication Publication Date Title
WO2006012385A2 (en) Crystalline mycophenolate sodium
EP3490973B1 (en) Polymorphic forms of belinostat and processes for preparation thereof
US20090076272A1 (en) Polymorphs of eszopiclone malate
KR20010088795A (ko) ＥｔＯ2Ｃ-ＣＨ2-(Ｒ)Ｃｇｌ-Ａｚｅ-Ｐａｂ-ＯＨ의 결정질형태
EP3953339B1 (en) Process for preparing 1-deoxy-1-methylamino-d-glucitol 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate
CA2457835A1 (en) Crystalline forms of valacyclovir hydrochloride
CN118525027A (zh) 还原型β‐烟酰胺单核苷酸二钠盐的多晶型及其制法和用途
CA2806820A1 (en) N-methylformamide solvate of dasatinib
KR100913684B1 (ko) Ｒ-티옥트산의 트로메타몰 염의 신규한 결정체, 이의 제조방법 및 이를 포함하는 약제
CA2464961A1 (en) Polymorphous forms of rosiglitazone maleate
US7531551B2 (en) Polymorphs of cabergoline
JP5442198B2 (ja) 医薬化合物の結晶形
KR20070012644A (ko) 약학 화합물의 결정체 형태
WO2011153221A1 (en) Solid state forms of ixabepilone
KR101418624B1 (ko) Ｎ­｛２­플루오로­5­［３­（티오펜­２­카보닐）­피라졸로［１，５­ａ］피리미딘­７­일］­페닐｝­ｎ­메틸­아세트아미드의 다형체 ｂ
MXPA06009148A (es) Formas cristalinasde un compuesto farmaceutico
EP1730153B1 (en) Isopropanol water solvate of olanzapine
TW202328152A (zh) 氮雜內醯胺化合物之晶型
WO2022271109A1 (en) New polymorph of vismodegib and method for its preparation
CN115448895A (zh) 一种沃替西汀前药的晶型、其制备方法和应用
KR100749219B1 (ko) 신규한 로지글리타존 옥살산염, 이의 제조방법, 및 이를포함하는 약제학적 조성물
CN116715662A (zh) 无定形的b-raf激酶二聚体抑制剂
EP2109613A2 (en) Polymorphs of eszopiclone malate
EP1768969A2 (en) Crystalline mycophenolate sodium

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application